Kingston Pharma Recalls DG Baby Gripe Water Due to Undissolved Ingredient
Kingston Pharma LLC is recalling DG Baby Gripe Water herbal supplements because they contain an undissolved ingredient, citrus flavonoid.
The agency’s classification
FDA (Food): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA has classified this recall as Class I. According to the severity rubric, if the agency's own classification is FDA Class I, the score must be at least 4 (Severe).
Plain-English summary
Kingston Pharma LLC is voluntarily recalling 138,752 bottles of DG Baby Gripe Water herbal supplement with organic ginger and fennel extracts, 4 FL OZ (120 mL) Liquid Dietary Supplement. The recall is being conducted because the product contains an undissolved ingredient, specifically citrus flavonoid.
The affected product is identified by UPC 8 54954 00246 3. The recall includes all lot codes. The product was distributed in 40 states across the United States, including Ohio, Florida, Arizona, Wisconsin, Michigan, Alabama, Colorado, Utah, New York, Oklahoma, California, Missouri, Illinois, Pennsylvania, Connecticut, Georgia, Texas, Tennessee, Nebraska, Massachusetts, Oregon, Virginia, New Jersey, Iowa, Indiana, Kentucky, Louisiana, Arkansas, Kansas, South Carolina, Mississippi, West Virginia, North Carolina, Maryland, Delaware, Maine, Minnesota, North Dakota, New Hampshire, Nevada, Rhode Island, South Dakota, and Vermont.
Consumers who have purchased this product should stop using it and return it to the place of purchase for a refund. The FDA has classified this recall as Class I, which is the most serious type of recall.
The recalled product
- Product
- DG Baby Gripe Water herbal supplement with organic ginger and fennel extracts, 4 FL OZ (120 mL) Liquid Dietary Supplement UPC: 8 54954 00246 3
- Manufacturer
- Kingston Pharma LLC
- Category
- Food — Dietary Supplement
- Hazard
- Affected units
- 138,752
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lot codes.
Distribution
Related recalls
Same manufacturer · Kingston Pharma LLC
See all →- SevereKingston Pharma Recalls Infant Cough Syrup Due to Microbial Contamination
FDA (Food) · 2019-05-08
- ModerateKingston Pharma Recalls Live Better Black Elderberry Syrup Due to Gas Development
FDA (Food) · 2018-02-21
Other food recalls
- SevereKayem Foods Recalls Ready-to-Eat Meat and Poultry Due to Temperature Abuse
USDA FSIS · 2026-10-17
- HighSaint Francis Apizza Frozen Pepperoni Pizza Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- SevereSweet Sensi THC Gum Drops Recalled for Staphylococcus aureus
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
Similar recalls
- SevereKingston Pharma Recalls Infant Cough Syrup Due to Microbial Contamination
FDA (Food) · 2019-05-08
- ModerateKingston Pharma Recalls Live Better Black Elderberry Syrup Due to Gas Development
FDA (Food) · 2018-02-21
- ModerateBaby Allergy herbal supplement recalled over unapproved drug claims and misbranding
FDA (Food) · 2025-12-31
- ModerateUS Pharmaceuticals Recalls Walgreens Glycerin Suppositories for Water Quality Issues
FDA (Drugs) · 2019-08-21
- SevereFDA Recalls Metabo-Plus Dietary Supplement for Undeclared Milk Allergen
FDA (Food) · 2017-08-23
- ModerateOrganic ginger root capsules recalled over unapproved drug claims and misbranding
FDA (Food) · 2025-12-31